Gilead Sciences Overview
Gilead Sciences Target Price
Analysts' 12-month price predictions for GILD.
Get informed when a big investor buys or sells
+ FollowShare Price
$131.27
Average Target Price
$160.29
22.1% upside
22.1% upside7 analysts in the last 4 months
High: $180 | Low: $122
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-01 | RBC CapitalBrian Abrahams | $122 |  7.1% downside |  |
| 2026-05-20 | Maxim GroupMichael Okunewitch | $165 | 25.7% upside | |
| 2026-05-10 | Morgan Stanley | $168 | 28% upside | |
| 2026-05-08 | Truist Financial | $157 | 19.6% upside | |
| 2026-04-10 | Morgan Stanley | $175 | 33.3% upside | |
| 2026-04-08 | Truist FinancialGregory Renza | $155 | 18.1% upside | |
| 2026-03-10 | JefferiesAkash Tewari | $180 | 37.1% upside | |
| 2026-02-19 | Barclays | $155 | 18.1% upside | |
| 2026-02-19 | Mizuho Securities | $170 | 29.5% upside | |
| 2026-02-18 | UBS | $175 | 33.3% upside | |
| 2026-02-11 | ScotiabankLouise Chen | $177 | 34.8% upside | |
| 2026-02-11 | BernsteinCourtney Breen | $160 | 21.9% upside | |
| 2026-02-11 | Morgan Stanley | $171 | 30.3% upside | |
| 2026-02-11 | Truist Financial | $162 | 23.4% upside | |
| 2026-02-11 | Truist Financial | $152 | 15.8% upside | |
| 2026-02-11 | Oppenheimer | $165 | 25.7% upside | |
| 2026-02-11 | Cantor Fitzgerald | $155 | 18.1% upside | |
| 2026-02-11 | NeedhamJoseph Stringer | $170 | 29.5% upside | |
| 2026-02-11 | Robert W. Baird | $145 | 10.5% upside | |
| 2026-02-11 | BMO CapitalEvan Seigerman | $160 | 21.9% upside | |
| 2026-02-11 | Wells FargoMohit Bansal | $165 | 25.7% upside | |
| 2026-01-27 | Truist Financial | $145 | 10.5% upside | |
| 2026-01-26 | BMO CapitalEvan David Seigerman | $150 | 14.3% upside | |
| 2026-01-26 | UBS | $155 | 18.1% upside | |
| 2026-01-13 | Morgan Stanley | $150 | 14.3% upside | |
| 2026-01-07 | UBSMichael Yee | $145 | 10.5% upside | |
| 2025-12-29 | BernsteinCourtney Breen | $135 | 2.8% upside | |
| 2025-12-15 | Wolfe ResearchAlexandria Hammond | $150 | 14.3% upside | |
| 2025-12-12 | Morgan Stanley | $151 | 15% upside | |
| 2025-12-10 | HSBC | $133 | 1.3% upside | |
| 2025-11-25 | BMO CapitalEvan David Seigerman | $135 | 2.8% upside | |
| 2025-11-24 | Truist FinancialGregory Renza | $140 | 6.7% upside | |
| 2025-11-20 | Mizuho Securities | $140 | 6.7% upside | |
| 2025-10-31 | Morgan StanleyTerence Flynn | $147 | 12% upside | |
| 2025-10-31 | RBC Capital | $105 | 20% downside | |
| 2025-10-31 | Wells Fargo | $145 | 10.5% upside | |
| 2025-10-09 | Cantor FitzgeraldCarter Gould | $135 | 2.8% upside | |
| 2025-10-06 | Wells Fargo | $140 | 6.7% upside | |
| 2025-08-11 | Deutsche BankJames Shin | $135 | 2.8% upside | |
| 2025-08-08 | Robert W. BairdBrian Skorney | $108 | 17.7% downside | |
| 2025-08-08 | Morgan StanleyTerence Flynn | $143 | 8.9% upside | |
| 2025-07-14 | Leerink PartnersDavid Risinger | $114 | 13.2% downside | |
| 2025-06-18 | Morgan StanleyTerence Flynn | $135 | 2.8% upside | |
| 2025-04-22 | Cantor FitzgeraldCarter Gould | $125 | 4.8% downside | |
| 2025-03-11 | Morgan StanleyTerence Flynn | $130 | 1% downside | |
| 2025-03-05 | Johnson Rice | $126 | 4% downside | |
| 2025-03-04 | Oppenheimer | $132 | 0.6% upside | |
| 2025-01-07 | RBC CapitalBrian Abrahams | $83 | 36.8% downside | |
| 2024-11-07 | Piper SandlerJoseph Catanzaro | $105 | 20% downside | |
| 2024-10-21 | BMO CapitalEvan David Seigerman | $94 | 28.4% downside | |